ADMA
Price
$19.33
Change
+$0.63 (+3.37%)
Updated
Aug 1 closing price
Capitalization
4.62B
4 days until earnings call
IMTX
Price
$6.48
Change
+$0.03 (+0.47%)
Updated
Aug 1 closing price
Capitalization
788.25M
10 days until earnings call
Interact to see
Advertisement

ADMA vs IMTX

Header iconADMA vs IMTX Comparison
Open Charts ADMA vs IMTXBanner chart's image
ADMA Biologics
Price$19.33
Change+$0.63 (+3.37%)
Volume$2.47M
Capitalization4.62B
Immatics
Price$6.48
Change+$0.03 (+0.47%)
Volume$386.24K
Capitalization788.25M
ADMA vs IMTX Comparison Chart in %
Loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADMA vs. IMTX commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a StrongBuy and IMTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2025
Stock price -- (ADMA: $19.33 vs. IMTX: $6.48)
Brand notoriety: ADMA and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 88% vs. IMTX: 63%
Market capitalization -- ADMA: $4.62B vs. IMTX: $788.25M
ADMA [@Biotechnology] is valued at $4.62B. IMTX’s [@Biotechnology] market capitalization is $788.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 2 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • ADMA’s FA Score: 2 green, 3 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ADMA is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • ADMA’s TA Score: 4 bullish, 5 bearish.
  • IMTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than ADMA.

Price Growth

ADMA (@Biotechnology) experienced а +7.33% price change this week, while IMTX (@Biotechnology) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

ADMA is expected to report earnings on Nov 05, 2025.

IMTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.62B) has a higher market cap than IMTX($788M). IMTX has higher P/E ratio than ADMA: IMTX (27.61) vs ADMA (23.02). ADMA YTD gains are higher at: 12.711 vs. IMTX (-8.861). ADMA has higher annual earnings (EBITDA): 161M vs. IMTX (-4.49M). IMTX has more cash in the bank: 544M vs. ADMA (71.6M). IMTX has less debt than ADMA: IMTX (18.4M) vs ADMA (82M). ADMA has higher revenues than IMTX: ADMA (459M) vs IMTX (144M).
ADMAIMTXADMA / IMTX
Capitalization4.62B788M586%
EBITDA161M-4.49M-3,587%
Gain YTD12.711-8.861-143%
P/E Ratio23.0227.6183%
Revenue459M144M319%
Total Cash71.6M544M13%
Total Debt82M18.4M446%
FUNDAMENTALS RATINGS
ADMA vs IMTX: Fundamental Ratings
ADMA
IMTX
OUTLOOK RATING
1..100
1618
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
18100
SMR RATING
1..100
1589
PRICE GROWTH RATING
1..100
4946
P/E GROWTH RATING
1..100
9963
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (61) in the null industry is in the same range as ADMA (76) in the Biotechnology industry. This means that IMTX’s stock grew similarly to ADMA’s over the last 12 months.

ADMA's Profit vs Risk Rating (18) in the Biotechnology industry is significantly better than the same rating for IMTX (100) in the null industry. This means that ADMA’s stock grew significantly faster than IMTX’s over the last 12 months.

ADMA's SMR Rating (15) in the Biotechnology industry is significantly better than the same rating for IMTX (89) in the null industry. This means that ADMA’s stock grew significantly faster than IMTX’s over the last 12 months.

IMTX's Price Growth Rating (46) in the null industry is in the same range as ADMA (49) in the Biotechnology industry. This means that IMTX’s stock grew similarly to ADMA’s over the last 12 months.

IMTX's P/E Growth Rating (63) in the null industry is somewhat better than the same rating for ADMA (99) in the Biotechnology industry. This means that IMTX’s stock grew somewhat faster than ADMA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADMAIMTX
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
76%
Bearish Trend 13 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSGAX23.03N/A
N/A
Columbia Select Large Cap Equity A
PRJBX45.80N/A
N/A
PGIM Jennison Global Opportunities R2
LSIUX12.60N/A
N/A
ClearBridge International Value IS
MIPIX15.79N/A
N/A
Matthews Asia Dividend Instl
CIQRX12.53N/A
N/A
Segall Bryant & Hamll Intl Eq Retl

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with IOVA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
+3.37%
IOVA - ADMA
45%
Loosely correlated
+4.28%
ACLX - ADMA
41%
Loosely correlated
-0.35%
IMTX - ADMA
40%
Loosely correlated
+0.47%
TARS - ADMA
40%
Loosely correlated
+5.13%
RNA - ADMA
39%
Loosely correlated
-2.15%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.47%
IDYA - IMTX
50%
Loosely correlated
-0.33%
OCUL - IMTX
50%
Loosely correlated
+2.94%
RGNX - IMTX
50%
Loosely correlated
-3.76%
DAWN - IMTX
48%
Loosely correlated
-0.89%
CRNX - IMTX
48%
Loosely correlated
-2.62%
More